GuruFocus
02 Sept 2026, 04:00 UTC · 3h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Analysis by Kasper Rasmussen · Founder & analyst
Top 1 mover · tap to explore
What the story claims
1 claim · each scored for market impact
Investors in Aardvark Therapeutics, Inc. (NAS:AARD) have the opportunity to lead a securities fraud lawsuit. — Allegations of securities fraud typically trigger negative investor sentiment and potential legal liabilities for the company.
-0.60Which stocks this story touches
The company is facing a securities fraud lawsuit.
Continue reading
6 related stories
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Newsfile Corp
6h ago
